Salt Lake City, UT, United States of America

Justin M Salvant

This inventor holds 2 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Curza Global, LLC, University of Utah Research Foundation. Active years: 2019-2022.

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.5

ph-index = 1


Company Filing History:


Years Active: 2019-2022

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Justin M Salvant: Innovator in Therapeutic Compositions

Introduction

Justin M Salvant is a notable inventor based in Salt Lake City, UT (US). He has made significant contributions to the field of therapeutic compositions, particularly in the development of compounds that exhibit selective activity against cancer cells. With a total of 2 patents, his work is paving the way for innovative treatments in oncology.

Latest Patents

Justin's latest patents include "Compositions and methods comprising substituted 2-aminoimidazoles" and "Compositions and methods comprising 2-(acylamino)imidazoles." Both inventions focus on 2-(acylamino)imidazoles, which demonstrate therapeutic activity, including selective activity against cancer cells. These patents also detail methods for using and preparing these compounds, showcasing their potential in medical applications.

Career Highlights

Throughout his career, Justin has worked with reputable organizations such as Curza Global, LLC and the University of Utah Research Foundation. His experience in these institutions has allowed him to collaborate with other experts in the field and further his research in therapeutic innovations.

Collaborations

Some of Justin's notable coworkers include Ryan E Looper and Bryan E Welm. Their collaborative efforts have contributed to the advancement of research in therapeutic compositions.

Conclusion

Justin M Salvant is a dedicated inventor whose work in therapeutic compositions is making a significant impact in the fight against cancer. His innovative patents and collaborations highlight his commitment to advancing medical science.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…